167 related articles for article (PubMed ID: 27581285)
1. A Protocol for a High-Throughput Multiplex Cell Viability Assay.
Gilbert DF; Boutros M
Methods Mol Biol; 2016; 1470():75-84. PubMed ID: 27581285
[TBL] [Abstract][Full Text] [Related]
2. A novel multiplex cell viability assay for high-throughput RNAi screening.
Gilbert DF; Erdmann G; Zhang X; Fritzsche A; Demir K; Jaedicke A; Muehlenberg K; Wanker EE; Boutros M
PLoS One; 2011; 6(12):e28338. PubMed ID: 22162763
[TBL] [Abstract][Full Text] [Related]
3. A Protocol for In Vitro High-Throughput Chemical Susceptibility Screening in Differentiating NT2 Stem Cells.
Menzner AK; Gilbert DF
Methods Mol Biol; 2017; 1601():61-70. PubMed ID: 28470517
[TBL] [Abstract][Full Text] [Related]
4. A high-throughput, multiplex cell death assay using an RNAi screening approach.
Falkenberg KJ; Saunders DN; Simpson KJ
Cold Spring Harb Protoc; 2014 Jun; 2014(6):663-76. PubMed ID: 24890208
[TBL] [Abstract][Full Text] [Related]
5. High-throughput viability assay using an autonomously bioluminescent cell line with a bacterial Lux reporter.
Class B; Thorne N; Aguisanda F; Southall N; McKew JC; Zheng W
J Lab Autom; 2015 Apr; 20(2):164-74. PubMed ID: 25447977
[TBL] [Abstract][Full Text] [Related]
6. Multiparametric luminescent cell viability assay in toxicology models: A critical evaluation.
Sali N; Nagy S; Poór M; Kőszegi T
J Pharmacol Toxicol Methods; 2016; 79():45-54. PubMed ID: 26777595
[TBL] [Abstract][Full Text] [Related]
7. Multiplexing high-content flow (HCF) and quantitative high-throughput screening (qHTS) to identify compounds capable of decreasing cell viability, activating caspase 3/7, expressing annexin V, and changing mitochondrial membrane integrity.
Mathews LA; Keller JM; McKnight C; Michael S; Shinn P; Liu D; Staudt LM; Thomas CJ; Ferrer M
Curr Protoc Chem Biol; 2013; 5(3):195-212. PubMed ID: 24391083
[TBL] [Abstract][Full Text] [Related]
8. Luminescence-Based, Low- and Medium-Throughput Assays for Drug Screening in Schistosoma mansoni Larval Stage.
Guidi A; Gimmelli R; Bresciani A; Ruberti G
Methods Mol Biol; 2020; 2151():219-227. PubMed ID: 32452008
[TBL] [Abstract][Full Text] [Related]
9. Accurate Cytotoxicity and Proliferation Determination: Advantages of a High-Throughput Phenotypic Approach Over ATP Luminescence Assays.
Hammerstein AF; Wylie PG
Assay Drug Dev Technol; 2016 Sep; 14(7):407-15. PubMed ID: 27504922
[TBL] [Abstract][Full Text] [Related]
10. Using iterative cluster merging with improved gap statistics to perform online phenotype discovery in the context of high-throughput RNAi screens.
Yin Z; Zhou X; Bakal C; Li F; Sun Y; Perrimon N; Wong ST
BMC Bioinformatics; 2008 Jun; 9():264. PubMed ID: 18534020
[TBL] [Abstract][Full Text] [Related]
11. Towards in vitro DT/DNT testing: Assaying chemical susceptibility in early differentiating NT2 cells.
Menzner AK; Abolpour Mofrad S; Friedrich O; Gilbert DF
Toxicology; 2015 Dec; 338():69-76. PubMed ID: 26498558
[TBL] [Abstract][Full Text] [Related]
12. High-throughput approaches to measuring cell death.
Saunders DN; Falkenberg KJ; Simpson KJ
Cold Spring Harb Protoc; 2014 Jun; 2014(6):591-601. PubMed ID: 24890217
[TBL] [Abstract][Full Text] [Related]
13. Development of cell-based high throughput luminescence assay for drug discovery in inhibiting OCT4/DNA-PKcs and OCT4-MK2 interactions.
Mohiuddin IS; Wei SJ; Yang IH; Martinez GM; Yang S; Cho EJ; Dalby KN; Kang MH
Biotechnol Bioeng; 2021 May; 118(5):1987-2000. PubMed ID: 33565603
[TBL] [Abstract][Full Text] [Related]
14. High throughput toxicity screening and intracellular detection of nanomaterials.
Collins AR; Annangi B; Rubio L; Marcos R; Dorn M; Merker C; Estrela-Lopis I; Cimpan MR; Ibrahim M; Cimpan E; Ostermann M; Sauter A; Yamani NE; Shaposhnikov S; Chevillard S; Paget V; Grall R; Delic J; de-Cerio FG; Suarez-Merino B; Fessard V; Hogeveen KN; Fjellsbø LM; Pran ER; Brzicova T; Topinka J; Silva MJ; Leite PE; Ribeiro AR; Granjeiro JM; Grafström R; Prina-Mello A; Dusinska M
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Jan; 9(1):. PubMed ID: 27273980
[TBL] [Abstract][Full Text] [Related]
15. High-Content Assay Multiplexing for Toxicity Screening in Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Hepatocytes.
Grimm FA; Iwata Y; Sirenko O; Bittner M; Rusyn I
Assay Drug Dev Technol; 2015 Nov; 13(9):529-46. PubMed ID: 26539751
[TBL] [Abstract][Full Text] [Related]
16. High-throughput screening for small molecule modulators of motor protein Kinesin.
Kadakkuzha BM; Spicer TP; Chase P; Richman JB; Hodder P; Puthanveettil SV
Assay Drug Dev Technol; 2014 Oct; 12(8):470-80. PubMed ID: 25383721
[TBL] [Abstract][Full Text] [Related]
17. High Throughput siRNA Screening Using Reverse Transfection.
von Schantz C; Saarela J
Methods Mol Biol; 2016; 1470():25-37. PubMed ID: 27581282
[TBL] [Abstract][Full Text] [Related]
18. A cell-based high-throughput screening assay for radiation susceptibility using automated cell counting.
Hodzic J; Dingjan I; Maas MJ; van der Meulen-Muileman IH; de Menezes RX; Heukelom S; Verheij M; Gerritsen WR; Geldof AA; van Triest B; van Beusechem VW
Radiat Oncol; 2015 Feb; 10():55. PubMed ID: 25888875
[TBL] [Abstract][Full Text] [Related]
19. Fluorescence microscopy-based RNA interference screening.
Gunkel M; Beil N; Beneke J; Reymann J; Erfle H
Methods Mol Biol; 2015; 1251():59-66. PubMed ID: 25391794
[TBL] [Abstract][Full Text] [Related]
20. High-throughput assessment of Mammalian cell viability by determination of adenosine triphosphate levels.
Tolliday N
Curr Protoc Chem Biol; 2010 Sep; 2(3):153-61. PubMed ID: 23839967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
